Ophthalmology CRO Services

KCAS has experience in preclinical ophthalmic research , ranging from identification and procurement of compounds to determining efficacy, tolerability, and PK studies. We give you the milestone data you need to make important decisions in the early stages of your ophthalmologic product development.

Talk to an expert

Complex ophthalmology studies demand specialist expertise

When developing products for the eye, your project needs a CRO with specialist experience and expertise. Many studies in ophthalmology are complex, and for this reason you need a team which understands the assessments and can focus on the details. KCAS knows how to provide high quality data for your ophthalmology drug development project.

Opthalmology treatment research, by leading scientists

There are a couple major challenges typically associated with ophthalmology as it relates to bioanalysis, one of the main being limited access to fluids or tissues from a living eye. It is difficult to develop highly sensitive methods when you can't use a lot of the matrix available. At KCAS, we have a rich history of conducting studies on eye tissues and using unique techniques that make a little sample go a long way in our processes. We have leveraged our rich history of knowing how to build a sensitive method with a minimal amount of volume. Additionally, our pharma team has become well-known for their PK analysis of small molecules, which makes us a perfect candidate for ophthalmological studies, as typically the treatment of the eye is a small molecule.

We employ rigorous quality practices that go beyond our competition. Processes are continuously improved to ensure we consistently deliver a complete outsourcing experience to clients.

KCAS Bio provides high quality science and data services that have benefits for the entire drug development journey.

Understand our approach

Agile, responsive, and easy to work with

We prepare and adapt our ophthalmology research based on a deep understanding of your drug development ambitions and wider business objectives.

Explore all services
What Can We Learn from Our Tears? Learn About a Recently Published Ocular Study by the Cell & Gene Therapy Department at KCAS Blogs
Read article What Can We Learn from Our Tears? Learn About a Recently Published Ocular Study by the Cell & Gene Therapy Department at KCAS

Recently, Matthew Pennington, PhD (one of KCAS’s Senior Scientists) was the senior author on a publication entitled “A Validated Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno Associated Viral Vectors in Bio Shedding Studies of Tears”. Below, Matt explains the significance in what they accomplished…

Tell us how we can help with your project

We've earned our reputation for delivering reliable, error-free data. We understand the importance of speed, flexibility, and consistency and only make promises we can keep.

Talk to an expert